Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of type 2 diabetes. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://theresasxlj374807.ka-blogs.com/92197880/semaglutide-a-potential-solution-for-metabolic-disorders